Bruker (BRKR) Total Non-Current Liabilities (2010 - 2026)
Bruker's (BRKR) quarterly Total Non-Current Liabilities came in at $3.1 billion in Q2 2026, down 19.06% on a YoY basis from $3.8 billion in Q2 2025, and little changed quarter-over-quarter from $3.1 billion in Q1 2026.
Analysis
Bruker (BRKR) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Bruker (BRKR) has reported Total Non-Current Liabilities for 17 consecutive years, with $3.1 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Non-Current Liabilities fell 19.06% year-over-year to $3.1 billion; the trailing twelve-month figure through Jun 2026 stood at $3.1 billion (down 19.06% YoY), and the FY2025 full-year result was $3.1 billion, down 14.91% from the prior year.
- Total Non-Current Liabilities steadied at $3.1 billion in Q2 2026 per BRKR's latest filing, from $3.1 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $4.1 billion in Q3 2024 and bottomed at $2.0 billion in Q2 2022.
- Historically, Total Non-Current Liabilities has averaged $2.9 billion across 5 years, with a median of $3.0 billion in 2024.
- The sharpest annual moves came in 2024 and 2026: Total Non-Current Liabilities jumped 85.72% in 2024, then fell 19.06% in 2026.
- Over 5 years, Total Non-Current Liabilities stood at $2.4 billion in 2022, then grew by 10.05% to $2.6 billion in 2023, then soared by 41.75% to $3.7 billion in 2024, then slipped by 14.91% to $3.1 billion in 2025, then fell by 2.45% to $3.1 billion in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $3.1 billion, $3.1 billion, and $3.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.99 Bn | 219.93 Bn | 8.34 Bn | 55.95 Bn |
| 2 | Danaher | 141.56 Bn | 137.22 Bn | 3.61 Bn | 33.25 Bn |
| 3 | Agilent Technologies | 40.36 Bn | 38.60 Bn | 1.04 Bn | 6.06 Bn |
| 4 | Illumina | 30.41 Bn | 29.24 Bn | 770.00 Mn | 3.52 Bn |
| 5 | Revvity | 13.50 Bn | 12.48 Bn | 416.87 Mn | 4.05 Bn |
| 6 | Bio-Techne | 11.25 Bn | 10.98 Bn | 211.39 Mn | 457.16 Mn |
| 7 | Bio-Rad Laboratories | 9.88 Bn | 8.26 Bn | 345.80 Mn | 2.88 Bn |
| 8 | Repligen | 9.29 Bn | 8.28 Bn | 110.04 Mn | 821.06 Mn |
| 9 | 10x Genomics | 8.62 Bn | 8.06 Bn | 112.50 Mn | 197.96 Mn |
| 10 | Bruker | 8.16 Bn | 7.94 Bn | 416.00 Mn | 3.06 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.06 Bn |
| Mar 31, 2026 | 3.05 Bn |
| Dec 31, 2025 | 3.13 Bn |
| Sep 30, 2025 | 3.30 Bn |
| Jun 30, 2025 | 3.77 Bn |
| Mar 31, 2025 | 3.44 Bn |
| Dec 31, 2024 | 3.68 Bn |
| Sep 30, 2024 | 4.06 Bn |
| Jun 30, 2024 | 3.90 Bn |
| Mar 31, 2024 | 2.89 Bn |
| Dec 31, 2023 | 2.60 Bn |
| Sep 30, 2023 | 2.19 Bn |
| Jun 30, 2023 | 2.19 Bn |
| Mar 31, 2023 | 2.17 Bn |
| Dec 31, 2022 | 2.36 Bn |
| Sep 30, 2022 | 2.01 Bn |
| Jun 30, 2022 | 2.00 Bn |
| Mar 31, 2022 | 2.09 Bn |
| Dec 31, 2021 | 2.40 Bn |
| Sep 30, 2021 | 1.64 Bn |